{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:19:14Z","timestamp":1787750354733,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This research compares the dosimetric characteristics of sequential boost (SB) and simultaneous integrated boost (SIB) techniques using intensity-modulated delivery techniques for breast radiotherapy in left-sided breast cancer patients following breast-conserving surgery (BCS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Twenty-seven left-sided breast cancer patients who underwent BCS were retrospectively analyzed. Two treatment plans per patient were generated using Eclipse Treatment Planning System. SB delivered 40 Gy\/15 fractions (four-arc volumetric modulated arc therapy [VMAT]) to whole breast, then 12.5 Gy\/5 fractions (six-field intensity-modulated radiotherapy [IMRT]) to tumor bed, totaling 52.5 Gy\/20 fractions. SIB delivered 40 Gy to whole breast and 48 Gy to tumor bed simultaneously in 15 fractions through four-arc VMAT. Target coverage, dose homogeneity, conformity, and organ-at-risk doses were compared using paired\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Both techniques achieved adequate target coverage with comparable whole breast mean doses. SB demonstrated significantly superior V95% coverage (98.4% vs. 95.7%), while SIB significantly achieved superior dose homogeneity within the integrated plan (HI: 0.31 \u00b1 0.025 vs. 0.14 \u00b1 0.032). SIB showed 31% reduction in total monitor units (10669 \u00b1 881 vs. 15450 \u00b1 1374 MU,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and 25% shorter treatment duration. SIB achieved superior left anterior descending artery sparing (mean: 5.70 \u00b1 1.78 vs. 6.54 \u00b1 2.64 Gy,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003) and spinal cord protection (maximum: 15.3 \u00b1 1.55 vs. 18.7 \u00b1 4.51 Gy,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). SB provided better ipsilateral lung sparing (mean: 11.8 \u00b1 1.44 vs. 12.4 \u00b1 1.04 Gy,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Both achieved mean heart doses &lt;5 Gy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Both techniques achieved adequate target coverage, SIB offers superior treatment efficiency and coronary artery sparing, while SB provides better V95% coverage and lung sparing. Technique selection should be individualized based on patient factors and institutional priorities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmp.jmp_16_26","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:01:43Z","timestamp":1782244903000},"page":"376-386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric Comparison of Sequential Boost versus Simultaneous Integrated Boost Intensity-modulated Delivery Techniques in Left-sided Breast Cancer Radiotherapy: A Planning Study"],"prefix":"10.4103","volume":"51","author":[{"given":"Mukesh Kumar","family":"Zope","sequence":"first","affiliation":[{"name":"Department of Medical Physics, State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Physics, Amity Institute of Applied Sciences, Amity University, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Goswami","sequence":"additional","affiliation":[{"name":"Deparment of Chemical Biological Radiological and Nuclear Defence, Institute of Nuclear Medicine and Allied Sciences Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"R1-20260623","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260623","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-20260623","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"R4-20260623","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","article-title":"Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France","volume":"15","author":"Romestaing","year":"1997","journal-title":"J Clin Oncol"},{"key":"R5-20260623","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1200\/JCO.2008.21.5764","article-title":"Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial","volume":"27","author":"Jones","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-20260623","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ijrobp.2006.05.041","article-title":"High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization","volume":"66","author":"Hurkmans","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20260623","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meddos.2005.11.001","article-title":"Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma","volume":"31","author":"Singla","year":"2006","journal-title":"Med Dosim"},{"key":"R8-20260623","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"R10-20260623","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1118\/1.2818738","article-title":"Volumetric modulated arc therapy: IMRT in a single gantry arc","volume":"35","author":"Otto","year":"2008","journal-title":"Med Phys"},{"key":"R11-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compmedimag.2016.10.001","article-title":"Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study","volume":"54","author":"Liu","year":"2016","journal-title":"Comput Med Imaging Graph"},{"key":"R12-20260623","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2009.05.038","article-title":"Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes","volume":"76","author":"Popescu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20260623","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"R14-20260623","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00066-017-1213-y","article-title":"Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease: Effects of modern radiotherapy techniques","volume":"194","author":"Corradini","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"R15-20260623","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-20260623","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20260623","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13014-015-0452-2","article-title":"Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques","volume":"10","author":"Aly","year":"2015","journal-title":"Radiat Oncol"},{"key":"R18-20260623","doi-asserted-by":"crossref","first-page":"e0120811","DOI":"10.1371\/journal.pone.0120811","article-title":"Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"R20-20260623","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"R21-20260623","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13014-016-0701-z","article-title":"Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results","volume":"11","author":"De Rose","year":"2016","journal-title":"Radiat Oncol"},{"key":"R22-20260623","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-015-0436-2","article-title":"Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy","volume":"10","author":"Skytt\u00e4","year":"2015","journal-title":"Radiat Oncol"},{"key":"R23-20260623","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2020.09.004","article-title":"Analysis of cardiac substructure dose in a large, multi-centre Danish breast cancer cohort (the DBCG HYPO trial): Trends and predictive modelling","volume":"153","author":"Finnegan","year":"2020","journal-title":"Radiother Oncol"},{"key":"R24-20260623","first-page":"1","article-title":"Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83","volume":"10","author":"Gr\u00e9goire","year":"2010","journal-title":"J ICRU"},{"key":"R25-20260623","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-20260623","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2007.01.037","article-title":"Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy","volume":"68","author":"van der Laan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R27-20260623","doi-asserted-by":"crossref","first-page":"e0145137","DOI":"10.1371\/journal.pone.0145137","article-title":"Performance of a knowledge-based model for optimization of volumetric modulated arc therapy plans for single and bilateral breast irradiation","volume":"10","author":"Fogliata","year":"2015","journal-title":"PLoS One"},{"key":"R28-20260623","first-page":"118","article-title":"Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial","volume":"28","author":"Thomsen","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"R29-20260623","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): A multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_16_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:26:42Z","timestamp":1787747202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_16_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_16_26","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}